NASDAQ · Financial Statements
Abivax S.A. (ABVX) Financial Statements
$136.94
NASDAQ: ABVX
Market Cap $10.06B
Overview Financials Dividend Abivax S.A. most recently reported annual revenue of $0, net profit of $-336.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-41.0M $-65.0M $-127.0M $-173.0M $-246.0M Net Profit $-42.0M $-61.0M $-148.0M $-176.0M $-336.0M EPS $-2.75 $-3.18 $-3.43 $-2.80 $-4.65 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $109.0M $76.0M $327.0M $205.0M $584.0M Total Liabilities $83.0M $68.0M $131.0M $165.0M $129.0M Cash $61.0M $27.0M $252.0M $144.0M $516.0M Borrowings $52.0M $39.0M $58.0M $97.0M $46.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-46.0M $-54.0M $-100.0M $-154.0M $-156.0M Investing Cash Flow $-3.0M $-12.0M $-11.0M $15.0M $-13.0M Financing Cash Flow $-10.0M $-4.0M $-28.0M $-10.0M $-1.0M Net Cash Flow $31.0M $-34.0M $225.0M $-108.0M $389.0M Free Cash Flow $-47.0M $-54.0M $-100.0M $-155.0M $-156.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.40 EV / EBITDA -32.75 FCF Yield -1.88% Quick Ratio 8.75 Interest Coverage -8.79 Return 1Y 35.48% Return 3Y — Return 5Y —
Screens featuring this stock